Neurotez Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Neurotez Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10807
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Neurotez Inc (Neurotez) is a biotechnology company that develops and markets leptin product, a novel hormone replacement therapy for Alzheimer’s disease (AD). The company’s product pipeline includes leptin, NT1, NT2, and others. Its product leptin is an adipocyte hormone that controls energy homeostasis and is used for the treatment of Alzheimer’s disease. Neurotez also develops a novel protein-protein interaction in a subset of familial cases of early onset Alzheimer’s disease and discovers CNS drugs. The company uses the screening methodology to identify the protein-protein interactions and novel protein targets for the drug development. Neurotez is headquartered in Bridgewater, New Jersey, the US.

Neurotez Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurotez Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Neurotez Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neurotez Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Neurotez Partners with KineMed 10
Licensing Agreements 11
Neurotez Enters into Licensing Agreement with GCA Therapeutics to Develop Leptin Derivatives 11
Equity Offering 12
Neurotez to Raise up to USD7 Million in Private Placement of Shares 12
Neurotez Inc – Key Competitors 13
Neurotez Inc – Key Employees 14
Neurotez Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Neurotez Inc, Pharmaceuticals & Healthcare, Key Facts 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurotez Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurotez Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Neurotez Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Neurotez Partners with KineMed 10
Neurotez Enters into Licensing Agreement with GCA Therapeutics to Develop Leptin Derivatives 11
Neurotez to Raise up to USD7 Million in Private Placement of Shares 12
Neurotez Inc, Key Competitors 13
Neurotez Inc, Key Employees 14

List of Figures
Neurotez Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Neurotez Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Neurotez Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Neurotez Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SilverSun Technologies Inc (SSNT):企業の財務・戦略的SWOT分析
    Summary SilverSun Technologies Inc (SilverSun) is a technology company that offers transformational business technology solutions and services for manufacturers and distributors. The company’s ERP software products comprise ERP X3, MAS90 and MAS200. It offers network services such as 24/7 remote net …
  • 3D Systems Corporation:企業の戦略・SWOT・財務情報
    3D Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary 3D Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The Navigator Company:企業の戦略・SWOT・財務情報
    The Navigator Company - Strategy, SWOT and Corporate Finance Report Summary The Navigator Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Blood Cell Storage Inc:医療機器:M&Aディール及び事業提携情報
    Summary Blood Cell Storage Inc (BCSI) is a medical device company that discovers and develops bio-medical technology products. The company’s products comprise IVF safe sens, platelets ph safe, and nucleic acid extraction systems, among others. Its IVF safe sens comprise trackstation and in-vessel mo …
  • Robert Half International Inc (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Brenntag Canada Inc:企業の戦略的SWOT分析
    Brenntag Canada Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • TG Therapeutics Inc (TGTX):企業の財務・戦略的SWOT分析
    TG Therapeutics Inc (TGTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • CTI BioPharma Corp (CTIC)-製薬・医療分野:企業M&A・提携分析
    Summary CTI BioPharma Corp (CTI BioPharma) is a biopharmaceutical company, which acquires, develops, and commercializes targeted therapies for a range of blood-related cancers. The company’s lead product, Pixuvri (pixantrone) is an aza-anthracenedione used for the treatment of multiply relapsed or r …
  • Brooks MacDonald Group PLC (BRK)
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Orpak Systems Limited:企業の戦略的SWOT分析
    Orpak Systems Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cessna Aircraft Company:企業の戦略・SWOT・財務分析
    Cessna Aircraft Company - Strategy, SWOT and Corporate Finance Report Summary Cessna Aircraft Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Spindletop Oil & Gas Co (SPND):石油・ガス:M&Aディール及び事業提携情報
    Summary Spindletop Oil & Gas Co (Spindletop Oil & Gas) is an oil and gas exploration and production company. The company explores, develops and produces crude oil and natural gas in North America. It owns and maintains natural gas pipeline in Texas. Spindletop Oil & Gas also operates various gas pip …
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Charter Communications, Inc.:戦略・SWOT・企業財務分析
    Charter Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Charter Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Lin Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lin Bioscience Inc (Lin Bioscience) is a drug development company that specializes in developing therapies for oncology, ophthalmology and other metabolic diseases. The company’s pipeline product LBS-008 is an oral therapy for treatment of macular degeneration; LBS-007 is a small molecular i …
  • DLF Limited:企業のM&A・事業提携・投資動向
    DLF Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DLF Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • PT Gudang Garam Tbk:企業の戦略・SWOT・財務情報
    PT Gudang Garam Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Gudang Garam Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Imperial College London-製薬・医療分野:企業M&A・提携分析
    Summary Imperial College London (Imperial) is a research university that offers educational services. The university provides undergraduate and postgraduate courses. It offers courses in the field of science and technology, agriculture, business, the humanities, and medicine. It conducts clinical tr …
  • Korab Resources Ltd (KOR):企業の財務・戦略的SWOT分析
    Summary Korab Resources Ltd (Korab) is a mining exploration company. The company’s business activities include evaluation, exploration, acquisition, production, and development of mineral resource properties. It explores for gold, potash, silver, tin, copper, rare earths, nickel, lead, zinc, magnesi …
  • Emmi AG:企業のM&A・事業提携・投資動向
    Emmi AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Emmi AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆